Medtronic, Venrock and others help take PowerVision to at least $53m raised in its history.
US-based medical technology company Medtronic has joined a consortium investing $24m in the series C round for US-based eye lens implant developer PowerVision after buying out two peers earlier this month.
Stephen Oesterle, senior vice president of medicine and technology at Medtronic has joined PowerVision’s board as an observer.
Medtronic joined venture capital firms Venrock, Advanced Technology Ventures, Frazier Healthcare Ventures and Panorama Capital in the round, which will help finance PowerVision’s research and development.
Advanced Technology and Frazier…
